Antiobesity Prescription Drugs Market

Anti-Obesity Prescription Drugs Market (By Drug Class - Bupropion and Naltrexone, Orlistat, Lorcaserin, Phentermine and Topiramate, Liraglutide; Age Group - Pediatric, Adult; Distribution Channel - Hospitals Pharmacies, Retail Pharmacies, E-commerce) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026

  • Rep Id : TMRGL34835
  • Published On : Nov 2017
  • No. of Pages : 170
  • Category : Pharmaceutical

1. Global Anti-Obesity Prescription Drugs  Market - Executive Summary

2. Global Anti-Obesity Prescription Drugs  Market Overview
     2.1. Introduction
            2.1.1. Global Anti-Obesity Prescription Drugs  Market Taxonomy
            2.1.2. Global Anti-Obesity Prescription Drugs  Market Definition
     2.2. Global Anti-Obesity Prescription Drugs  Market Size (US$ Mn) and Forecast, 2012-2026
            2.2.1. Global Anti-Obesity Prescription Drugs  Market Y-o-Y Growth
     2.3. Global Anti-Obesity Prescription Drugs  Market Dynamics
     2.4. Supply Chain
     2.5. Cost Structure
     2.6. Pricing Analysis 
     2.7. PESTLE Analysis
     2.8. Product Life Cycle Analysis
     2.9. Key Regulations
     2.10. Patents
     2.11. List of Distributors
     2.12. Key Participants Market Presence (Intensity Map) By Region

3. Global Anti-Obesity Prescription Drugs  Market Analysis and Forecast 2012-2026 
     3.1. Global Anti-Obesity Prescription Drugs  Market Size and Forecast By Drug Class, 2012-2026
            3.1.1. Bupropion and Naltrexone Market Size and Forecast, 2012-2026
                     3.1.1.1. Revenue (US$ Mn) Comparison, By Region
                     3.1.1.2. Market Share Comparison, By Region
                     3.1.1.3. Y-o-Y growth Comparison, By Region
            3.1.2. Orlistat Market Size and Forecast, 2012-2026
                     3.1.2.1. Revenue (US$ Mn) Comparison, By Region
                     3.1.2.2. Market Share Comparison, By Region
                     3.1.2.3. Y-o-Y growth Comparison, By Region
            3.1.3. Lorcaserin Market Size and Forecast, 2012-2026
                     3.1.3.1. Revenue (US$ Mn) Comparison, By Region
                     3.1.3.2. Market Share Comparison, By Region
                     3.1.3.3. Y-o-Y growth Comparison, By Region
            3.1.4. Phentermine and Topiramate Market Size and Forecast, 2012-2026
                     3.1.4.1. Revenue (US$ Mn) Comparison, By Region
                     3.1.4.2. Market Share Comparison, By Region
                     3.1.4.3. Y-o-Y growth Comparison, By Region
            3.1.5. Liraglutide Market Size and Forecast, 2012-2026
                     3.1.5.1. Revenue (US$ Mn) Comparison, By Region
                     3.1.5.2. Market Share Comparison, By Region
                     3.1.5.3. Y-o-Y growth Comparison, By Region
     3.2. Global Anti-Obesity Prescription Drugs  Market Size and Forecast By Age Group, 2012-2026
            3.2.1. Pediatric Market Size and Forecast, 2012-2026
                     3.2.1.1. Revenue (US$ Mn) Comparison, By Region
                     3.2.1.2. Market Share Comparison, By Region
                     3.2.1.3. Y-o-Y growth Comparison, By Region
            3.2.2. Adult  Market Size and Forecast, 2012-2026
                     3.2.2.1. Revenue (US$ Mn) Comparison, By Region
                     3.2.2.2. Market Share Comparison, By Region
                     3.2.2.3. Y-o-Y growth Comparison, By Region
     3.3. Global Anti-Obesity Prescription Drugs  Market Size and Forecast By Distribution Channel, 2012-2026
            3.3.1. Hospitals Pharmacies Market Size and Forecast, 2012-2026
                     3.3.1.1. Revenue (US$ Mn) Comparison, By Region
                     3.3.1.2. Market Share Comparison, By Region
                     3.3.1.3. Y-o-Y growth Comparison, By Region
            3.3.2. Retail Pharmacies Market Size and Forecast, 2012-2026
                     3.3.2.1. Revenue (US$ Mn) Comparison, By Region
                     3.3.2.2. Market Share Comparison, By Region
                     3.3.2.3. Y-o-Y growth Comparison, By Region
            3.3.3. E-commerce Market Size and Forecast, 2012-2026
                     3.3.3.1. Revenue (US$ Mn) Comparison, By Region
                     3.3.3.2. Market Share Comparison, By Region
                     3.3.3.3. Y-o-Y growth Comparison, By Region

4. North America Anti-Obesity Prescription Drugs  Market Size and Forecast, 2012-2026
     4.1. Revenue (US$ Mn) Comparison, By Country 
     4.2. Revenue (US$ Mn) Comparison, By Drug Class 
     4.3. Revenue (US$ Mn) Comparison, By Age Group 
     4.4. Revenue (US$ Mn) Comparison, By Distribution Channel 

5. Latin America Anti-Obesity Prescription Drugs  Market Size and Forecast, 2012-2026
     5.1. Revenue (US$ Mn) Comparison, By Country 
     5.2. Revenue (US$ Mn) Comparison, By Drug Class 
     5.3. Revenue (US$ Mn) Comparison, By Age Group 
     5.4. Revenue (US$ Mn) Comparison, By Distribution Channel 

6. Europe Anti-Obesity Prescription Drugs  Market Size and Forecast, 2012-2026
     6.1. Revenue (US$ Mn) Comparison, By Country 
     6.2. Revenue (US$ Mn) Comparison, By Drug Class 
     6.3. Revenue (US$ Mn) Comparison, By Age Group 
     6.4. Revenue (US$ Mn) Comparison, By Distribution Channel 

7. Japan Anti-Obesity Prescription Drugs  Market Size and Forecast, 2012-2026
     7.1. Revenue (US$ Mn) Comparison, By Country 
     7.2. Revenue (US$ Mn) Comparison, By Drug Class 
     7.3. Revenue (US$ Mn) Comparison, By Age Group 
     7.4. Revenue (US$ Mn) Comparison, By Distribution Channel 

8. APEJ Anti-Obesity Prescription Drugs  Market Size and Forecast, 2012-2026
     8.1. Revenue (US$ Mn) Comparison, By Country 
     8.2. Revenue (US$ Mn) Comparison, By Drug Class 
     8.3. Revenue (US$ Mn) Comparison, By Age Group 
     8.4. Revenue (US$ Mn) Comparison, By Distribution Channel 

9. MEA Anti-Obesity Prescription Drugs  Market Size and Forecast, 2012-2026
     9.1. Revenue (US$ Mn) Comparison, By Country 
     9.2. Revenue (US$ Mn) Comparison, By Drug Class 
     9.3. Revenue (US$ Mn) Comparison, By Age Group 
     9.4. Revenue (US$ Mn) Comparison, By Distribution Channel 

10. Global Anti-Obesity Prescription Drugs  Market Company Share, Competition Landscape and Company Profiles
     10.1. Company Share Analysis
     10.2. Competition Landscape
     10.3. Company Profiles
            10.3.1. VIVUS Inc.
            10.3.2. Novo Nordisk A/S
            10.3.3. GlaxoSmithKline PLC
            10.3.4. Roche Holding AG
            10.3.5. Arena Pharmaceuticals, Inc.
            10.3.6. Orexigen Therapeutics, Inc.
            10.3.7. Merck & Co Inc.
            10.3.8. Sun Pharmaceutical Industries Limited
            10.3.9 Takeda Pharmaceutical Company Limited
            10.3.10 Pfizer Inc.

11. Research Methodology

12. Secondary and Primary Sources

13. Assumptions and Acronyms

14. Disclaimer

 List of Tables

TABLE 1 Global Anti-Obesity Prescription Drugs Market Value (US$ Mn), 2012-2017
TABLE 2 Global Anti-Obesity Prescription Drugs Market Value (US$ Mn), 2018-2026
TABLE 3 Global Anti-Obesity Prescription Drugs Market Value (US$ Mn) and Y-o-Y, 2017-2026
TABLE 4 Global Bupropion and Naltrexone Segment Value (US$ Mn), By Region 2012-2017
TABLE 5 Global Bupropion and Naltrexone Segment Value (US$ Mn), By Region 2018-2026
TABLE 6 Global Bupropion and Naltrexone Segment Market Share, By Region 2012-2017
TABLE 7 Global Bupropion and Naltrexone Segment Market Share, By Region 2018-2026
TABLE 8 Global Bupropion and Naltrexone Segment Y-o-Y, By Region 2017-2026
TABLE 9 Global Orlistat Segment Value (US$ Mn), By Region 2012-2017
TABLE 10 Global Orlistat Segment Value (US$ Mn), By Region 2018-2026
TABLE 11 Global Orlistat Segment Market Share, By Region 2012-2017
TABLE 12 Global Orlistat Segment Market Share, By Region 2018-2026
TABLE 13 Global Orlistat Segment Y-o-Y, By Region 2017-2026
TABLE 14 Global Lorcaserin Segment Value (US$ Mn), By Region 2012-2017
TABLE 15 Global Lorcaserin Segment Value (US$ Mn), By Region 2018-2026
TABLE 16 Global Lorcaserin Segment Market Share, By Region 2012-2017
TABLE 17 Global Lorcaserin Segment Market Share, By Region 2018-2026
TABLE 18 Global Lorcaserin Segment Y-o-Y, By Region 2017-2026
TABLE 19 Global Phentermine and Topiramate Segment Value (US$ Mn), By Region 2012-2017
TABLE 20 Global Phentermine and Topiramate Segment Value (US$ Mn), By Region 2018-2026
TABLE 21 Global Phentermine and Topiramate Segment Market Share, By Region 2012-2017
TABLE 22 Global Phentermine and Topiramate Segment Market Share, By Region 2018-2026
TABLE 23 Global Phentermine and Topiramate Segment Y-o-Y, By Region 2017-2026
TABLE 24 Global Liraglutide Segment Value (US$ Mn), By Region 2012-2017
TABLE 25 Global Liraglutide Segment Value (US$ Mn), By Region 2018-2026
TABLE 26 Global Liraglutide Segment Market Share, By Region 2012-2017
TABLE 27 Global Liraglutide Segment Market Share, By Region 2018-2026
TABLE 28 Global Liraglutide Segment Y-o-Y, By Region 2017-2026
TABLE 29 Global Pediatric Segment Value (US$ Mn), By Region 2012-2017
TABLE 30 Global Pediatric Segment Value (US$ Mn), By Region 2018-2026
TABLE 31 Global Pediatric Segment Market Share, By Region 2012-2017
TABLE 32 Global Pediatric Segment Market Share, By Region 2018-2026
TABLE 33 Global Pediatric Segment Y-o-Y, By Region 2017-2026
TABLE 34 Global Adult Segment Value (US$ Mn), By Region 2012-2017
TABLE 35 Global Adult Segment Value (US$ Mn), By Region 2018-2026
TABLE 36 Global Adult Segment Market Share, By Region 2012-2017
TABLE 37 Global Adult Segment Market Share, By Region 2018-2026
TABLE 38 Global Adult Segment Y-o-Y, By Region 2017-2026
TABLE 39 Global Hospitals Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 40 Global Hospitals Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 41 Global Hospitals Pharmacies Segment Market Share, By Region 2012-2017
TABLE 42 Global Hospitals Pharmacies Segment Market Share, By Region 2018-2026
TABLE 43 Global Hospitals Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 44 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2012-2017
TABLE 45 Global Retail Pharmacies Segment Value (US$ Mn), By Region 2018-2026
TABLE 46 Global Retail Pharmacies Segment Market Share, By Region 2012-2017
TABLE 47 Global Retail Pharmacies Segment Market Share, By Region 2018-2026
TABLE 48 Global Retail Pharmacies Segment Y-o-Y, By Region 2017-2026
TABLE 49 Global E-commerce Segment Value (US$ Mn), By Region 2012-2017
TABLE 50 Global E-commerce Segment Value (US$ Mn), By Region 2018-2026
TABLE 51 Global E-commerce Segment Market Share, By Region 2012-2017
TABLE 52 Global E-commerce Segment Market Share, By Region 2018-2026
TABLE 53 Global E-commerce Segment Y-o-Y, By Region 2017-2026
TABLE 54 North America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 55 North America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 56 North America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 57 North America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 58 North America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2012-2017
TABLE 59 North America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2018-2026
TABLE 60 North America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 61 North America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 62 Latin America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 63 Latin America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 64 Latin America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 65 Latin America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 66 Latin America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2012-2017
TABLE 67 Latin America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2018-2026
TABLE 68 Latin America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 69 Latin America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 70 Europe Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 71 Europe Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 72 Europe Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 73 Europe Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 74 Europe Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2012-2017
TABLE 75 Europe Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2018-2026
TABLE 76 Europe Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 77 Europe Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 78 Japan Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 79 Japan Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 80 Japan Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 81 Japan Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 82 Japan Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2012-2017
TABLE 83 Japan Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2018-2026
TABLE 84 Japan Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 85 Japan Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 86 APEJ Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 87 APEJ Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 88 APEJ Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 89 APEJ Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 90 APEJ Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2012-2017
TABLE 91 APEJ Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2018-2026
TABLE 92 APEJ Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 93 APEJ Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
TABLE 94 MEA Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2012-2017
TABLE 95 MEA Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2018-2026
TABLE 96 MEA Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2012-2017
TABLE 97 MEA Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2018-2026
TABLE 98 MEA Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2012-2017
TABLE 99 MEA Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2018-2026
TABLE 100 MEA Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
TABLE 101 MEA Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026

 List of Figures

FIG. 1 Global Anti-Obesity Prescription Drugs Market Value (US$ Mn), 2012-2017
FIG. 2 Global Anti-Obesity Prescription Drugs Market Value (US$ Mn) Forecast, 2018-2026
FIG. 3 Global Anti-Obesity Prescription Drugs Market Value (US$ Mn) and Y-o-Y, 2017-2026
FIG. 4 Global Bupropion and Naltrexone Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 5 Global Bupropion and Naltrexone Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 6 Global Bupropion and Naltrexone Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 7 Global Orlistat Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 8 Global Orlistat Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 9 Global Orlistat Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 10 Global Lorcaserin Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 11 Global Lorcaserin Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 12 Global Lorcaserin Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 13 Global Phentermine and Topiramate Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 14 Global Phentermine and Topiramate Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 15 Global Phentermine and Topiramate Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 16 Global Liraglutide Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 17 Global Liraglutide Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 18 Global Liraglutide Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 19 Global Pediatric Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 20 Global Pediatric Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 21 Global Pediatric Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 22 Global Adult Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 23 Global Adult Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 24 Global Adult Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 25 Global Hospitals Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 26 Global Hospitals Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 27 Global Hospitals Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 28 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 29 Global Retail Pharmacies Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 30 Global Retail Pharmacies Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 31 Global E-commerce Segment Market Value (US$ Mn) By Region, 2012-2017
FIG. 32 Global E-commerce Segment Market Value (US$ Mn) By Region, 2018-2026
FIG. 33 Global E-commerce Segment Y-o-Y Growth Rate, By Region, 2017-2026
FIG. 34 North America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 35 North America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 36 North America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 37 North America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 38 North America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2012-2017
FIG. 39 North America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2018-2026
FIG. 40 North America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 41 North America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 42 Latin America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 43 Latin America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 44 Latin America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 45 Latin America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 46 Latin America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2012-2017
FIG. 47 Latin America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2018-2026
FIG. 48 Latin America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 49 Latin America Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 50 Europe Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 51 Europe Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 52 Europe Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 53 Europe Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 54 Europe Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2012-2017
FIG. 55 Europe Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2018-2026
FIG. 56 Europe Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 57 Europe Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 58 Japan Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 59 Japan Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 60 Japan Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 61 Japan Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 62 Japan Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 63 Japan Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2018-2026
FIG. 64 Japan Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 65 Japan Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 66 APEJ Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 67 APEJ Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 68 APEJ Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 69 APEJ Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 70 APEJ Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2012-2017
FIG. 71 APEJ Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2018-2026
FIG. 72 APEJ Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 73 APEJ Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026
FIG. 74 MEA Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2012-2017
FIG. 75 MEA Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Country 2018-2026
FIG. 76 MEA Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2012-2017
FIG. 77 MEA Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Drug Class 2018-2026
FIG. 78 MEA Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2012-2017
FIG. 79 MEA Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Age Group 2018-2026
FIG. 80 MEA Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2012-2017
FIG. 81 MEA Anti-Obesity Prescription Drugs Market Value (US$ Mn), By Distribution Channel 2018-2026

.